| | This week's FierceLifeSci is brought to you by Drug Development Forum. | | Leading pharmaceutical and biotech professionals will convene in Boston this September for the FierceBiotech Drug Development Forum (DDF) to discuss and evaluate the latest challenges, trends and innovation in drug discovery, research, and development. Will you be there? Register today to secure low early bird rates. Prices go up next month!
| |
The program is in its final stages of development and we're excited to share a sneak peak of a few sessions and speakers! Three distinct tracks - Research & Development (R&D), Partnering & Deals (P&D), and CROs & Outsourcing (C&O) will provide insight into multiple aspects of the entire drug development process.
How to Strike a $1 Billion Deal
Biotech IPOs in 2017
Early Research Analytics to drive Precision Medicine and increased PTRS
Partnerships in Immuno-Oncology
Translational R&D Transformation
Click here to view more sessions.
| | |
|
|
|
| Bardia Akbari
Genentech, Inc. | Mark Baglin
Shire | Mark Barrett
Sanofi Genzyme | Kathrin Jansen
Pfizer | |
|
|
|
| Marian Nakada
Johnson & Johnson | Anna Protopapas
Mersana Therapeutics | Simos Simeonidas
RBC Capital Markets | Susan Shiff
Merck |
Click here to view more speakers.
|
|
Want to reach 300,000+ FierceLifeSci subscribers with your own message?
Contact aalcover@fiercemarkets.com or call 202-824-5074.
About this email: In order to receive FierceLifeSci for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe. FierceMarkets 1900 L St. NW Suite we 400 Washington, DC 20036 | . |
